The document appears to be a market report containing sales data for pharmaceutical drugs. It includes sales figures in terms of volume (number of prescriptions) and value (dollars) for various drugs across months and years. It compares individual drug performance to overall market benchmarks and competitors. Specific drugs mentioned include those targeting epilepsy, anxiety, and seizures, among the top selling drugs for companies Ranbaxy and Solus.